Ares Genetics GmbH Company
Ares Genetics develops Artificial Intelligence informed DNA-Sequencing Tests to revolutionize Infectious Disease and Drug Resistance Testing
Funding Status:
Seed
Industry:
Data Processing
Estimated Revenue:
Less than $1M
Technology:
Analytics, Artificial Intelligence, Biotechnology, Health Care, Life Science, Machine Learning, Pharmaceutical
Headquarters:
Vienna, Wien, Austria
Total Funding:
1300000.0
Last Funding Date:
2019-01-08
Last Funding Type:
Seed
Employee Number:
1-10
Investors Number:
1.0
Founded Date:
2017-01-01